These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 25661065

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. GSK-3β and vitamin D receptor are involved in β-catenin and snail signaling in high glucose-induced epithelial-mesenchymal transition of mouse podocytes.
    Guo J, Xia N, Yang L, Zhou S, Zhang Q, Qiao Y, Liu Z.
    Cell Physiol Biochem; 2014; 33(4):1087-96. PubMed ID: 24732862
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
    Sun J, Yan P, Chen Y, Chen Y, Yang J, Xu G, Mao H, Qiu Y.
    Diagn Pathol; 2015 Jun 19; 10():72. PubMed ID: 26088648
    [Abstract] [Full Text] [Related]

  • 4. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
    Neelam S, Brooks MM, Cammarata PR.
    Mol Vis; 2014 Jun 19; 20():1758-75. PubMed ID: 25593505
    [Abstract] [Full Text] [Related]

  • 5. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ, Han HJ.
    Am J Physiol Renal Physiol; 2010 May 19; 298(5):F1263-75. PubMed ID: 20015942
    [Abstract] [Full Text] [Related]

  • 6. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.
    Paeng J, Chang JH, Lee SH, Nam BY, Kang HY, Kim S, Oh HJ, Park JT, Han SH, Yoo TH, Kang SW.
    Apoptosis; 2014 Dec 19; 19(12):1678-90. PubMed ID: 25284613
    [Abstract] [Full Text] [Related]

  • 7. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes.
    Wan J, Li P, Liu DW, Chen Y, Mo HZ, Liu BG, Chen WJ, Lu XQ, Guo J, Zhang Q, Qiao YJ, Liu ZS, Wan GR.
    Mol Med Rep; 2016 Aug 19; 14(2):1771-84. PubMed ID: 27357417
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glycogen synthase kinase‑3β is required for epithelial‑mesenchymal transition and barrier dysfunction in mouse podocytes under high glucose conditions.
    Guo J, Yang L, Qiao Y, Liu Z.
    Mol Med Rep; 2016 Nov 19; 14(5):4091-4098. PubMed ID: 27748847
    [Abstract] [Full Text] [Related]

  • 12. [Phosphorylation of glycogen synthase kinase-3beta induces epithelial mesenchymal transition in human peritoneal mesothelial cells].
    Fan M, Liu F, Yang Y, Ye Y, Huang G.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr 19; 35(4):329-34. PubMed ID: 20448354
    [Abstract] [Full Text] [Related]

  • 13. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
    Ono M, Matsubara Y, Shibano T, Ikeda Y, Murata M.
    Platelets; 2011 Apr 19; 22(3):196-203. PubMed ID: 21231855
    [Abstract] [Full Text] [Related]

  • 14. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
    Ji XK, Xie YK, Zhong JQ, Xu QG, Zeng QQ, Wang Y, Zhang QY, Shan YF.
    Acta Pharmacol Sin; 2015 Mar 19; 36(3):334-42. PubMed ID: 25661318
    [Abstract] [Full Text] [Related]

  • 15. Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering β-catenin transcriptional activity under high glucose conditions.
    Lv Z, Hu M, Zhen J, Lin J, Wang Q, Wang R.
    Int J Biochem Cell Biol; 2013 Feb 19; 45(2):255-64. PubMed ID: 23153508
    [Abstract] [Full Text] [Related]

  • 16. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
    Ho MY, Tang SJ, Chuang MJ, Cha TL, Li JY, Sun GH, Sun KH.
    Mol Cancer Res; 2012 Aug 19; 10(8):1109-19. PubMed ID: 22707636
    [Abstract] [Full Text] [Related]

  • 17. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
    Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W, Xing L.
    Mol Immunol; 2012 Aug 19; 52(1):38-49. PubMed ID: 22580404
    [Abstract] [Full Text] [Related]

  • 18. miR-135 family members mediate podocyte injury through the activation of Wnt/β-catenin signaling.
    Yang X, Wang X, Nie F, Liu T, Yu X, Wang H, Li Q, Peng R, Mao Z, Zhou Q, Li G.
    Int J Mol Med; 2015 Sep 19; 36(3):669-77. PubMed ID: 26134897
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-139-5p regulates C2C12 cell myogenesis through blocking Wnt/β-catenin signaling pathway.
    Mi L, Li Y, Zhang Q, Zhao C, Peng Y, Yang G, Zheng X.
    Biochem Cell Biol; 2015 Feb 19; 93(1):8-15. PubMed ID: 25529604
    [Abstract] [Full Text] [Related]

  • 20. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
    Zhang B, Yang Y, Shi X, Liao W, Chen M, Cheng AS, Yan H, Fang C, Zhang S, Xu G, Shen S, Huang S, Chen G, Lv Y, Ling T, Zhang X, Wang L, Zhuge Y, Zou X.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):704-12. PubMed ID: 25449432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.